Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,336,000
-$8,393,350 QoQ
Shares Held
50,000
-47.4% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#83
of 307 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Mar 31, 2020CallValue
$39,413,500
CallShares
350,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. ASND ranks #31 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
640,000 | $214,265,600 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $136,234,886 | |
| 3 | PBLS |
Parabilis Medicines, Inc.
|
4,615,612 | $126,329,300 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
2,657,521 | $110,738,900 | |
| 5 | ERAS |
Erasca, Inc.
|
6,000,000 | $109,920,000 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
2,510,000 | $101,981,300 | |
| 7 | EYPT |
EyePoint, Inc.
|
7,000,000 | $100,100,000 | |
| 8 | ALMS |
Alumis Inc.
|
3,285,596 | $92,456,671 |
All Filings in ASND
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,336,000 | 50,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,729,350 | 95,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,324,000 | 100,000 | Shares | Defined | 2026-02-17 | |
| 2022-12-31 | $6,106,500 | 50,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,163,000 | 50,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,648,000 | 50,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,868,000 | 50,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,726,500 | 50,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,096,300 | 170,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,866,250 | 75,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,888,000 | 100,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,678,000 | 100,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $19,290,000 | 125,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,882,500 | 175,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $39,413,500 | 350,000 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $28,152,500 | 250,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||